Quantumzyme Corp. (OTC: QTZM), a biotransformation company specializing in enzyme-based solutions for pharmaceutical manufacturing, announced today that it plans to attend the 2026 BIO International Convention, scheduled for June 22–25, 2026, in San Diego, California. The BIO International Convention is a premier global gathering of biotechnology and life sciences companies, academic institutions, and industry participants, representing a broad range of scientific and commercial disciplines.
Representatives of Quantumzyme expect to attend the conference and engage in informal networking meetings with industry participants. The Company will not be presenting, exhibiting, sponsoring, or formally participating in conference programming. According to Naveen Kulkarni, Chief Executive Officer of Quantumzyme Corp., 'We view the BIO International Convention as an important opportunity to connect with peers across the biotechnology and biomanufacturing ecosystem. Our attendance is focused on listening, learning, and engaging in informal discussions with industry participants as we continue to evaluate developments relevant to our technology and long-term objectives.'
Quantumzyme’s attendance is limited to observation and networking activities only and is consistent with the Company’s ongoing efforts to increase industry awareness and maintain dialogue with potential collaborators, technology partners, and other stakeholders. There can be no assurance that discussions initiated during the conference will result in any agreements, transactions, or future business relationships. Additional information regarding the BIO International Convention is available at https://convention.bio.org.
Quantumzyme Corp. is a biotransformation company focused on advancing sustainable enzyme-based solutions for pharmaceutical manufacturing. Specializing in green chemistry, the Company applies quantum mechanics, molecular modeling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support environmentally responsible production. By integrating computational modeling with laboratory validation, Quantumzyme aims to deliver scalable, cost-effective biocatalysis solutions that improve industrial sustainability.
For more information and updates, please visit www.quantumzymecorp.com and the Company’s profile at www.otcmarkets.com/stock/QTZM. The information contained in this press release is provided by Quantumzyme Corp. for general informational purposes only and includes forward-looking statements that involve risks and uncertainties.
